The pharmacy chain is keeping up with the change in the retail landscape.

CVS Health Corp. posted their third-quarter earnings today, and despite the difficulties the COVID-19 pandemic has caused to numerous physical retailers, the company’s emphasis on health and healthcare seems to be providing upward momentum.

According to CVS’ report, earnings for Q3 landed at $1.66 per share. This is a drop compared to the same time last year, but still an improvement over Wall Street’s expectations of $1.33 per share. Same store sales are up by 5.7%, which not only beats Wall Street’s estimates, but is actually an improvement over last year. Thanks to this improvement, CVS has upped their expectations for the last few months of the year, seeing adjusted earnings in the ballpark of $7.335 to $7.45 per share.

“Our strong third quarter results demonstrate continued execution of our long-term strategic plan that is transforming the way health care is delivered,” said CVS CEO Larry Merlo. “As an integrated health services provider, we’re developing holistic and innovative solutions that meet the needs of our customers in the community, in the home or in the palm of their hand.”

“Our comprehensive pandemic response shows the power of a diverse and agile enterprise. We’ve opened more than 4,000 COVID-19 test sites across the country since March, and have administered over six million tests,” he added. “We’re helping businesses and universities safely reopen and we were recently selected to administer COVID-19 vaccinations in long-term care facilities. We’ll continue to play a vital role in our nation’s recovery thanks to the tireless efforts of our nearly 300,000 employees.”

While my charitable trust owns $CVS, understand that it has historically been blasted by sellers after the conference call https://t.co/2Cj9QmVLog

— Jim Cramer (@jimcramer) November 6, 2020

During this announcement, it was also revealed that Merlo, who has headed CVS for the last 9 years, will be stepping down from his position in February of 2021 to retire. His replacement will be Karen Lynch, the current head of CVS’ Aetna Healthcare Unit.